Thrombotic Thrombocytopenic Purpura Induced by Immune Checkpoint Inhibitiors: A Case Report and Review of the Literature

In recent years, the role of immune checkpoint inhibitors (ICI) in cancer treatment has rapidly expanded. In randomized clinical trials, these agents have demonstrated clinical efficacy in extending survival and increasing response rates. Immune-related adverse effects (irAEs) involving various orga...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Zeeshan, Zafar, Muhammad Usman, Wolfe, Zachary, Akbar, Faisal, Lash, Bradley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7707147/
https://www.ncbi.nlm.nih.gov/pubmed/33274128
http://dx.doi.org/10.7759/cureus.11246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7707147/
https://www.ncbi.nlm.nih.gov/pubmed/33274128
http://dx.doi.org/10.7759/cureus.11246

Ejemplares similares